Full-Length Transcriptome Sequencing and RNA-Seq Analysis Offer Insights into Terpenoid Biosynthesis in Blumea balsamifera (L.) DC
- PMID: 38540346
- PMCID: PMC10970515
- DOI: 10.3390/genes15030285
Full-Length Transcriptome Sequencing and RNA-Seq Analysis Offer Insights into Terpenoid Biosynthesis in Blumea balsamifera (L.) DC
Abstract
Blumea balsamifera (L.) DC., an important economic and medicinal herb, has a long history of being used as a traditional Chinese medicine. Its leaves have always been used as a raw material for the extraction of essential oils, comprising large amounts of terpenoids, which have good therapeutic effects on many diseases, such as eczema, bacterial infection, and hypertension. However, the genetic basis of terpenoid biosynthesis in this plant is virtually unknown on account of the lack of genomic data. Here, a combination of next-generation sequencing (NGS) and full-length transcriptome sequencing was applied to identify genes involved in terpenoid biosynthesis at five developmental stages. Then, the main components of essential oils in B. balsamifera were identified using GC-MS. Overall, 16 monoterpenoids and 20 sesquiterpenoids were identified and 333,860 CCS reads were generated, yielding 65,045 non-redundant transcripts. Among these highly accurate transcripts, 59,958 (92.18%) transcripts were successfully annotated using NR, eggNOG, Swissprot, KEGG, KOG, COG, Pfam, and GO databases. Finally, a total of 56 differently expressed genes (DEGs) involved in terpenoid biosynthesis were identified, including 38 terpenoid backbone genes and 18 TPSs, which provide a significant amount of genetic information for B. balsamifera. These results build a basis for resource protection, molecular breeding, and the metabolic engineering of this plant.
Keywords: Blumea balsamifera; L-borneol; SMART; essential oil; terpene synthase.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures










Similar articles
-
Functional characterization of four mono-terpene synthases (TPSs) provided insight into the biosynthesis of volatile monoterpenes in the medicinal herb Blumea balsamifera.Physiol Mol Biol Plants. 2023 Apr;29(4):459-469. doi: 10.1007/s12298-023-01306-8. Epub 2023 Apr 29. Physiol Mol Biol Plants. 2023. PMID: 37187774 Free PMC article.
-
Full-Length Transcriptomic Sequencing and Temporal Transcriptome Expression Profiling Analyses Offer Insights into Terpenoid Biosynthesis in Artemisia argyi.Molecules. 2022 Sep 13;27(18):5948. doi: 10.3390/molecules27185948. Molecules. 2022. PMID: 36144681 Free PMC article.
-
[Analysis of metabolic pathway of terpenoids in Blumea balsamifera].Zhongguo Zhong Yao Za Zhi. 2016 May;41(9):1585-1591. doi: 10.4268/cjcmm20160903. Zhongguo Zhong Yao Za Zhi. 2016. PMID: 28891603 Chinese.
-
Biosynthesis of monoterpenoid and sesquiterpenoid as natural flavors and fragrances.Biotechnol Adv. 2023 Jul-Aug;65:108151. doi: 10.1016/j.biotechadv.2023.108151. Epub 2023 Apr 8. Biotechnol Adv. 2023. PMID: 37037288 Review.
-
Phytochemical composition and health properties of Sembung plant (Blumea balsamifera): A review.Vet World. 2021 May;14(5):1185-1196. doi: 10.14202/vetworld.2021.1185-1196. Epub 2021 May 17. Vet World. 2021. PMID: 34220120 Free PMC article. Review.
Cited by
-
Diversity of organ-specific plant transcriptomes.Acta Biochim Pol. 2025 Jul 16;72:14609. doi: 10.3389/abp.2025.14609. eCollection 2025. Acta Biochim Pol. 2025. PMID: 40740964 Free PMC article. Review.
-
Exploring the role and mechanisms of the PMA gene in Aspergillus fumigatus.Mycology. 2024 Jun 3;16(1):280-292. doi: 10.1080/21501203.2024.2354273. eCollection 2025. Mycology. 2024. PMID: 40083401 Free PMC article.
-
Comparative Proteomics and Metabonomics Analysis of Different Diapause Stages Revealed a New Regulation Mechanism of Diapause in Loxostege sticticalis (Lepidoptera: Pyralidae).Molecules. 2024 Jul 25;29(15):3472. doi: 10.3390/molecules29153472. Molecules. 2024. PMID: 39124877 Free PMC article.
References
-
- Yuan Y., Pang Y.X., Wang W.Q., Zhang Y.B., Yu J.B. Investigation on the plant resources of Blumea balsamifera (L.) DC. in China. J. Trop. Biol. 2011;2:78–82.
-
- Guan L.L., Pang Y.X., Wang D., Zhang Y.B., Wu K.Y. Research progress on Chinese Minority Medicine of Blumea balsamifera L. DC. J. Plant Genet. Res. 2012;13:695–698.
-
- Hasegawa H., Yamada Y., Komiyama K., Hayashi M., Ishibashi M., Yoshida T., Sakai T., Koyano T., Kam T.S., Murata K., et al. Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells. Blood. 2006;107:679–688. doi: 10.1182/blood-2005-05-1982. - DOI - PubMed
-
- Saewan N., Koysomboon S., Chantrapromma K. Anti-tyrosinase and anti-cancer activities of flavonoids from Blumea balsamifera DC. J. Med. Plants Res. 2011;5:1018–1025.
Publication types
MeSH terms
Substances
Grants and funding
- 2018[1011] and [2019]1019/Guizhou Science and Technology Department
- Grant No. [2021]163/Research and Demonstration on Key technologies for conservation and Innovative utilization of germplasm resources of important Southern medicine in Guangdong Province
- Grant No. ZQ2018004/'Thousand' level Innovative Talents Project in Guizhou Province
LinkOut - more resources
Full Text Sources
Miscellaneous